TANASESCU, RADU and LEYS, DIDIER, 2023. Brain-specific biomarkers: on the winding path to accessibility and clinical relevance. European journal of neurology.
FRANCIS, ANNA G, ELHADD, KARIEM, CAMERA, VALENTINA, FERREIRA DOS SANTOS, MONICA, ROCCHI, CHIARA, ADIB-SAMII, PONEH, ATHWAL, BAL, ATTFIELD, KATHRINE, BARRITT, ANDREW, CRANER, MATTHEW, FISNIKU, LEONORA, IVERSEN, ASTRID K N, LEACH, OLIVER, MATTHEWS, LUCY, REDMOND, IAN, O'RIORDAN, JONATHAN, SCALFARI, ANTONIO, TANASESCU, RADU, WREN, DAMIAN, HUDA, SAIF, LEITE, MARIA ISABEL, FUGGER, LARS and PALACE, JACQUELINE, 2023. Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination. Neurology(R) neuroimmunology & neuroinflammation. 10(1),
MATHUR, M, GRAN, B, TANASESCU, R, CONSTANTINESCU, C and BAYRAKTUTAN, U, 2022. Sera from Patients with Multiple Sclerosis in Relapse or Remission Affect the Blood-Brain Barrier Differently: An In vitro Study SVOA Neurology. 3(5), 168- 173
ASTBURY, LAUREN, KALRA, SEEMA, TANASESCU, RADU and CONSTANTINESCU, CRIS S., 2022. CSF lymphocytic pleocytosis does not predict a less favourable long-term prognosis in MS JOURNAL OF NEUROLOGY.
ALTOKHIS, A., ALOTAIBI, A., PODLASEK, A., TENCH, C. and TANASESCU, R., 2022. Predictors of long-term disability in MS patients using routine MRI data: a 15-year retrospective study MULTIPLE SCLEROSIS JOURNAL. 28(3_SUPPL), 792-793
TANASESCU, RADU and CHAN, ANDREW, 2022. To predict or not to predict: Multiple sclerosis and B-cell subset-specific genetic risk scores EUROPEAN JOURNAL OF NEUROLOGY.
DOBSON, RUTH, TANASESCU, RADU and GRAN, BRUNO, 2022. Editorial: Preventing multiple sclerosis FRONTIERS IN NEUROLOGY. 13,
MAPLE, PETER A., ASCHERIO, ALBERTO, COHEN, JEFFREY I., CUTTER, GARY, GIOVANNONI, GAVIN, SHANNON-LOWE, CLAIRE, TANASESCU, RADU and GRAN, BRUNO, 2022. The Potential for EBV Vaccines to Prevent Multiple Sclerosis FRONTIERS IN NEUROLOGY. 13,
CONSTANTINESCU, C. S., TANASESCU, R. and PRITCHARD, D. I., 2022. Neutrophil-to-Lymphocyte Ratio as a Biomarker of Response to Immunomodulation: Findings of the WIRMS Trial of Hookworm in RMS MULTIPLE SCLEROSIS JOURNAL. 28(1_SUPPL), 40-41
TANASESCU, RADU and REINDL, MARKUS, 2022. Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated disease EUROPEAN JOURNAL OF NEUROLOGY. 29(6), 1569-1570
TENCH, C. R., TANASESCU, R., CONSTANTINESCU, C. S., AUER, D. P. and COTTAM, W. J., 2022. Easy to interpret coordinate based meta-analysis of neuroimaging studies: Analysis of brain coordinates (ABC) JOURNAL OF NEUROSCIENCE METHODS. 372,
DHILLON, PERMESH SINGH, DINEEN, ROBERT A., MORRIS, HALEY, TANASESCU, RADU, NIKFEKR, ESMAEIL, EVANS, JONATHAN, CONSTANTINESCU, CRIS S. and HOSSEINI, AKRAM A., 2021. Neurological Disorders Associated With COVID-19 Hospital Admissions: Experience of a Single Tertiary Healthcare Center FRONTIERS IN NEUROLOGY. 12, ALLEN, C. M., RAMSAMY, S., TARR, A. W., TIGHE, P. J., IRVING, W. L., TANASESCU, R. and EVANS, J. R., 2021. Guillain-Barre Syndrome Variant Occurring after SARS-CoV-2 Vaccination: Ann Neurol Ann Neurol. 90(2), 315-318 ARAM, J., FRAKICH, N., MORANDI, E., ALROUJI, M., SAMARAWEERA, A., ONION, D., SPENDLOVE, I., COLOMBO, S. L., TANASESCU, R., GRAN, B. and CONSTANTINESCU, C. S., 2020. Increased IL-2 and Reduced TGF-beta Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis: Biomedicines Biomedicines. 8(7), TANASESCU, R., TENCH, C. R., CONSTANTINESCU, C. S., TELFORD, G., SINGH, S., FRAKICH, N., ONION, D., AUER, D. P., GRAN, B., EVANGELOU, N., FALAH, Y., RANSHAW, C., CANTACESSI, C., JENKINS, T. P. and PRITCHARD, D. I., 2020. Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial: JAMA Neurol JAMA Neurol. 77(9), 1089-1098 MORANDI, E., TANASESCU, R., TARLINTON, R.E., CONSTANTIN-TEODOSIU, D. and GRAN, B., 2019. Do Antiretroviral Drugs Protect From Multiple Sclerosis By Inhibiting Expression Of MS-Associated Retrovirus? Frontiers in Immunology. 9, 3092 DUMITRESCU, LAURA, CONSTANTINESCU, CRIS S. and TANASESCU, RADU, 2019. Siponimod for the treatment of secondary progressive multiple sclerosis EXPERT OPINION ON PHARMACOTHERAPY. 20(2), 143-150 CHOU, I. J., KUO, C. F., TANASESCU, R., TENCH, C. R., TILEY, C. G., CONSTANTINESCU, C. S. and WHITEHOUSE, W. P., 2019. Epilepsy and associated mortality in patients with multiple sclerosis EUROPEAN JOURNAL OF NEUROLOGY. 26(2), 342-+ MORANDI, ELENA, TANASESCU, RADU, TARLINTON, RACHAEL E., CONSTANTIN-TEODOSIU, DUMITRU and GRAN, BRUNO, 2019. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus? FRONTIERS IN IMMUNOLOGY. 9, MAPLE, PETER A C, TANASESCU, RADU, GRAN, BRUNO and CONSTANTINESCU, CRIS S, 2019. A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls. The Journal of infection.
CHOU, I-JUN, TANASESCU, RADU, MOUGIN, OLIVIER E., GOWLAND, PENNY A., TENCH, CHRISTOPHER R., WHITEHOUSE, WILLIAM P., GRAN, BRUNO, NIKFEKR, ESMAEIL, SHARRACK, BASIL, MAZIBRADA, GORDON and CONSTANTINESCU, CRIS S., 2019. Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging SCIENTIFIC REPORTS. 9, MORANDI E, TANASESCU R, TARLINTON RE, CONSTANTIN-TEODOSIU D and GRAN B, 2019. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus? Frontiers in immunology. 9, 3092 ARAM, JEHAN, FRANCIS, ANNA, TANASESCU, RADU and CONSTANTINESCU, CRIS S, 2018. Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis. Neurology and therapy.
DUMITRESCU, LAURA, CONSTANTINESCU, CRIS S. and TANASESCU, RADU, 2018. Recent developments in interferon-based therapies for multiple sclerosis EXPERT OPINION ON BIOLOGICAL THERAPY. 18(6), 665-680 CHOU, I-JUN, LIM, SU-YIN, TANASESCU, RADU, AL-RADAIDEH, ALI, MOUGIN, OLIVIER E., TENCH, CHRISTOPHER R., WHITEHOUSE, WILLIAM P., GOWLAND, PENNY A. and CONSTANTINESCU, CRIS S., 2018. Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions JOURNAL OF NEUROIMAGING. 28(2), 183-190 CONSTANTINESCU, CRIS S., FRAKICH, NANCI, THEVATHAS, SARAH, TANASESCU, RADU, GRAN, BRUNO, SPENDLOVE, IAN, CHANG, CHERRY and JONES, RHODRI, 2018. Mesenchymal Stem Cells from Patients with Secondary Progressive Multiple Sclerosis Show Deficient Immunomodulatory Activity towards Homologous Immune Cells NEUROLOGY. 90,
PAPATHANASIOU, A., CONSTANTINESCU, C., GILMORE, C., EVANGELOU, N., GRAN, B., NIKFEKR, E. and TANASESCU, R., 2018. The clinical spectrum of MOG antibody-associated demyelination: a retrospective case study MULTIPLE SCLEROSIS JOURNAL. 24, 744-745
CONSTANTINESCU, C., FRAKICH, N., THEVATHAS, S., TANASESCU, R., GRAN, B., ONION, D., SPENDLOVE, I., BATH, P., LOUISE, S., KOSSENKOV, A., CHANG, C. and JONES, R., 2018. Mesenchymal stem cells from patients with MS in interaction with autologous immune cells have defective immunomodulatory activity and enhance production of inflammatory cytokines MULTIPLE SCLEROSIS JOURNAL. 24, 186-187
HOSSAIN MJ, MORANDI E, TANASESCU R, FRAKICH N, CALDANO M, ONION D, FARAJ TA, ERRIDGE C and GRAN B, 2018. The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker. Frontiers in immunology. 9, 457 HOSSAIN,MD JAKIR, MORANDI,ELENA, TANASESCU,RADU, FRAKICH,NANCI, CALDANO,MARZIA, ONION,DAVID, FARAJ,TOLA A., ERRIDGE,CLETT and GRAN,BRUNO, 2018. The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker: Frontiers in Immunology Front Immunol. 9(457), MORANDI E, TANASESCU R, TARLINTON RE, CONSTANTINESCU CS, ZHANG W, TENCH C and GRAN B, 2017. The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis. PloS one. 12(2), e0172415 MORANDI E, TARLINTON RE, TANASESCU R and GRAN B, 2017. Human endogenous retroviruses and multiple sclerosis: Causation, association, or after-effect? Multiple sclerosis (Houndmills, Basingstoke, England). 1352458517704711 TENCH CR, TANASESCU R, CONSTANTINESCU C, AUER DP and COTTAM WJ, 2017. Coordinate based random effect size meta-analysis of neuroimaging studies NeuroImage. 153, 293-306 TENCH CR, TANASESCU R, CONSTANTINESCU CS, AUER DP and COTTAM WJ, 2017. Coordinate based random effect size meta-analysis of neuroimaging studies. NeuroImage. 153, 293-306 MANOUCHEHRINIA, ALI, TANASESCU, RADU, KAREEM, HUNER, JERCA, OLTITA P., JABEEN, FOUZIA, SHAFEI, RACHELLE, BREUER, JUDITH, NEAL, KEITH, IRVING, WILLIAM and CONSTANTINESCU, CRIS S., 2017. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis JOURNAL OF NEUROVIROLOGY. 23(6), 839-844 MORANDI, ELENA, TARLINTON, RACHAEL E., TANASESCU, RADU and GRAN, BRUNO, 2017. Human endogenous retroviruses and multiple sclerosis: Causation, association, or after-effect? MULTIPLE SCLEROSIS JOURNAL. 23(8), 1050-1055 HOSSAIN, MD JAKIR, TANASESCU, RADU and GRAN, BRUNO, 2017. Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2 JOURNAL OF NEUROIMMUNOLOGY. 304, 11-20
MORANDI, ELENA, TANASESCU, RADU, TARLINTON, RACHAEL E., CONSTANTINESCU, CRIS S., ZHANG, WEIYA, TENCH, CHRISTOPHER and GRAN, BRUNO, 2017. The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis PLOS ONE. 12(2), TANASESCU, R., COTTAM, W.J., CONDON, L., TENCH, C.R. and AUER, D.P., 2016. Functional reorganisation in chronic pain and neural correlates of pain sensitisation: A coordinate based meta-analysis of 266 cutaneous pain fMRI studies Neuroscience and Biobehavioral Reviews. 68, 120-133 COCLITU C, CONSTANTINESCU CS and TANASESCU R, 2016. The future of multiple sclerosis treatments. Expert review of neurotherapeutics. 16(12), 1341-1356 TANASESCU, RADU, COTTAM, WILLIAM J., CONDON, LAURA, TENCH, CHRISTOPHER R. and AUER, DOROTHEE P., 2016. Functional reorganisation in chronic pain and neural correlates of pain sensitisation: A coordinate based meta-analysis of 266 cutaneous pain fMRI studies NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 68, 120-133 TENCH, C R, TANASESCU, RADU, COTTAM, W J, CONSTANTINESCU, C S and AUER, D P, 2016. Coordinate based meta-analysis does not show grey matter atrophy in narcolepsy. Neuroscience and biobehavioral reviews.
CONSTANTINESCUS, CRIS, MANOUCHEHRINIA, ALI, TANASESCU, RADU, KAREEM, HUNER, JERCA, OLTITA and IRVING, WILLIAM, 2016. The Prevalence of a History of Prior VZV/HZV Infection in MS: A Survey Study with Serological Validation Sub-Study NEUROLOGY. 86,
HOSSAIN, M. J., MORANDI, E., TANASESCU, R., FARAJ, T. A., ERRIDGE, C. and GRAN, B., 2016. Role of Toll-like receptor 2 in mediating infection and inflammation in multiple sclerosis MULTIPLE SCLEROSIS JOURNAL. 22, 183-183
JEAN-GILLES L, BRAITCH M, LATIF ML, ARAM J, FAHEY AJ, EDWARDS LJ, ROBINS RA, TANASESCU R, TIGHE PJ, GRAN B, SHOWE LC, ALEXANDER SP, CHAPMAN V, KENDALL DA and CONSTANTINESCU CS, 2015. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. Acta physiologica (Oxford, England). 214(1), 63-74 VILISAAR J, KAWABE K, BRAITCH M, ARAM J, FURTUN Y, FAHEY AJ, CHOPRA M, TANASESCU R, TIGHE PJ, GRAN B, POTHOULAKIS C and CONSTANTINESCU CS, 2015. Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. PMID: 25690155, JEAN-GILLES, L., BRAITCH, M., LATIF, M. L., ARAM, J., FAHEY, A. J., EDWARDS, L. J., ROBINS, R. A., TANASESCU, R., TIGHE, P. J., GRAN, B., SHOWE, L. C., ALEXANDER, S. P., CHAPMAN, V., KENDALL, D. A. and CONSTANTINESCU, C. S., 2015. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells Acta Physiologica. 214(1), 63-74 VILISAAR, J., KAWABE, K., BRAITCH, M., ARAM, J., FURTUN, Y., FAHEY, A. J., CHOPRA, M., TANASESCU, R., TIGHE, P. J., GRAN, B., POTHOULAKIS, C. and CONSTANTINESCU, C. S., 2015. Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNgamma/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis: J Neuroimmune Pharmacol J Neuroimmune Pharmacol. JEAN-GILLES, L., BRAITCH, M., LATIF, M. L., ARAM, J., FAHEY, A. J., EDWARDS, L. J., ROBINS, R. A., TANASESCU, R., TIGHE, P. J., GRAN, B., SHOWE, L. C., ALEXANDER, S. P., CHAPMAN, V., KENDALL, D. A. and CONSTANTINESCU, C. S., 2015. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells: Acta Physiol (Oxf) Acta Physiol (Oxf). 214(1), 63-74 TANASESCU R, TENCH CR, COTTAM WJ, CONSTANTINESCU CS and AUER DP, 2015. Coordinate based meta-analysis does not show grey matter atrophy in narcolepsy. Neuroscience and biobehavioral reviews. 57, 297-8 CHOU, I. J., TANASESCU, R., MOUGIN, O. E., TENCH, C. R., GRAN, B., WHITEHOUSE, W. P., GOWLAND, P. A. and CONSTANTINESCU, C. S., 2015. Changes in the normal appearing white matter in neuromyelitis optica measured by MRI at 7T field strength: Multiple Sclerosis Journal Multiple Sclerosis Journal. 21, 206-207
TANASESCU, RADU, TENCH, CHRISTOPHER R., COTTAM, WILLIAM J., CONSTANTINESCU, CRIS S. and AUER, DOROTHEE P., 2015. Coordinate based meta-analysis does not show grey narcolepsy NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 57, 297-298
JURYŃCZYK M, WEINSHENKER B, AKMAN-DEMIR G, ASGARI N, BARNES D, BOGGILD M, CHAUDHURI A, D'HOOGHE M, EVANGELOU N, GERALDES R, ILLES Z, JACOB A, KIM HJ, KLEITER I, LEVY M, MARIGNIER R, MCGUIGAN C, MURRAY K, NAKASHIMA I, PANDIT L, PAUL F, PITTOCK S, SELMAJ K, DE SÈZE J, SIVA A, TANASESCU R, VUKUSIC S, WINGERCHUK D, WREN D, LEITE I and PALACE J, 2015. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. Journal of neurology. 263(1), 140-9 CONSTANTINESCU CS, ASHER A, FRYZE W, KOZUBSKI W, WAGNER F, ARAM J, TANASESCU R, KOROLKIEWICZ RP, DIRNBERGER-HERTWECK M, STEIDL S, LIBRETTO SE, SPRENGER T and RADUE EW, 2015. Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Neurology(R) neuroimmunology & neuroinflammation. 2(4), e117 KHAN UT, TANASESCU R and CONSTANTINESCU CS, 2015. PEGylated IFNβ-1a in the treatment of multiple sclerosis. Expert opinion on biological therapy. 15(7), 1077-84 MANOUCHEHRINIA A, TANASESCU R, TENCH CR and CONSTANTINESCU CS, 2015. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. Journal of neurology, neurosurgery, and psychiatry. 87(3), 324-31 CHOU, I. J., TANASESCU, R., MOUGIN, O. E., TENCH, C. R., GRAN, B., WHITEHOUSE, W. P., GOWLAND, P. A. and CONSTANTINESCU, C. S., 2015. Changes in the normal appearing white matter in neuromyelitis optica measured by MRI at 7T field strength: Multiple Sclerosis Journal Multiple Sclerosis Journal. 21, 206-207 HOSSAIN MJ, TANASESCU R and GRAN B, 2015. TLR2: an innate immune checkpoint in multiple sclerosis. Oncotarget. 6(34), 35131-2 I-JUN CHOU, WILLIAM P WHITEHOUSE, HUEI-SHYONG WANG and RADU TANASESCU, 2014. Diagnostic Modalities in Multiple Sclerosis: Perspectives in Children Biomed J. 37(2), 50-59 TANASESCU R and CONSTANTINESCU CS, 2014. Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis. Expert opinion on drug metabolism & toxicology. 10(4), 621-30 MAHADEVA A, TANASESCU R and GRAN B, 2014. Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital. American journal of clinical and experimental immunology. 3(1), 57-67
TANASESCU R and CONSTANTINESCU CS, 2014. Helminth Therapy for MS. Current topics in behavioral neurosciences. 26, 195-220 TANASESCU R, EVANGELOU N and CONSTANTINESCU CS, 2013. Role of oral teriflunomide in the management of multiple sclerosis. Neuropsychiatric disease and treatment. 9, 539-53 TANASESCU R and CONSTANTINESCU CS, 2013. Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. Expert opinion on drug metabolism & toxicology. (In Press.)
TENCH, , CHRISTOPHER R. AND TANASESCU, , RADU AND AUER, , DOROTHEE P. AND CONSTANTINESCU, , CRIS S., 2013. Coordinate Based Meta-Analysis of Functional Neuroimaging Data; False Discovery Control and Diagnostics PLoS ONE. 8(7), e70143 ANGHEL D, TANASESCU R, CAMPEANU A, LUPESCU I, PODDA G and BAJENARU O, 2013. Neurotoxicity of immunosuppressive therapies in organ transplantation. Mædica. 8(2), 170-5
PETRESCU S, TRIFANESCU R, IONESCU P, VANGHELIE GD, TANASESCU R, MOLDOVAN M, MUNJEV N, BAJENARU O and PANEA C, 2013. Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients. Mædica. 8(1), 11-6
TENCH, CHRISTOPHER R., TANASESCU, RADU, AUER, DOROTHEE P. and CONSTANTINESCU, CRIS S., 2013. Coordinate Based Meta-Analysis of Functional Neuroimaging Data; False Discovery Control and Diagnostics PLOS ONE. 8(7),
TANASESCU R, ROG D and CONSTANTINESCU CS, 2011. A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'. Expert opinion on drug discovery. 6(4), 437-52 TITULAER MJ, SOFFIETTI R, DALMAU J, GILHUS NE, GIOMETTO B, GRAUS F, GRISOLD W, HONNORAT J, SILLEVIS SMITT PAE, TANASESCU R, VEDELER CA, VOLTZ R, VERSCHUUREN JJGM and EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES, 2011. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. European journal of neurology : the official journal of the European Federation of Neurological Societies. 18(1), 19-e3 TANASESCU R and CONSTANTINESCU CS, 2010. Cannabinoids And The Immune System: An Overview. Immunobiology. 215(8), 588-97 GALVIN R, BRÅTHEN G, IVASHYNKA A, HILLBOM M, TANASESCU R, LEONE MA and EFNS, 2010. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European journal of neurology : the official journal of the European Federation of Neurological Societies. 17(12), 1408-18 HRISTEA A, CONSTANTINESCU RVM, EXERGIAN F, ARAMA V, BESLEAGA M and TANASESCU R, 2008. Paraplegia due to non-osseous spinal tuberculosis: report of three cases and review of the literature. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 12(4), 425-9 MAZIGHI M, TANASESCU R, DUCROCQ X, VICAUT E, BRACARD S, HOUDART E and WOIMANT F, 2006. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 66(8), 1187-91 TANASESCU R, DEBOUVERIE M, PITTION S, ANXIONNAT R and VESPIGNANI H, 2004. Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient. Journal of neurology. 251(6), 762-3 TANASESCU R, KREMER S, TAILLANDIER L, LACOUR J, BRACARD S and PICARD L, 2004. [What is your diagnosis?]. Journal of neuroradiology. Journal de neuroradiologie. 31(5), 397-8 INGRAM CD, CIOBANU R, COCULESCU IL, TANASESCU R, COCULESCU M and MIHAI R, 1998. Vasopressin neurotransmission and the control of circadian rhythms in the suprachiasmatic nucleus. Progress in brain research. 119, 351-64
CHOU I, WHITEHOUSE WP, WANG H, TANASESCU R and CONSTANTINESCU CS, 1. Diagnostic modalities in multiple sclerosis: perspectives in children. Biomedical journal. 37(2), 50-9 TANASESCU R, IONETE C, CHOU I and CONSTANTINESCU CS, 1. Advances in the treatment of relapsing-remitting multiple sclerosis. Biomedical journal. 37(2), 41-9